Ischemic heart diseases patients. ischemic heart diseases
Conditions
Interventions
Intervention 1: Intervention group: intervention group will recieve 2 mg Colchicine three times divided dose with standard treatments control group will only recieve standard treatments and placebo.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Ischemic heart diseases and diabetic patients; age 18-85; undergoing of angioplasty with stent insertion; filling of consent form.
Exclusion criteria
Exclusion criteria: Elevation of CK-MB and cTnI before PCI; history of CABG during last three months; history of previous MI; renal dysfunction (creatinine above 2.5 mg/dl); unsuccessful PCI; acute MI; cardiogenic shock; dialysis; pregnancy; inability in filling and understanding of the consent form; unconsented patients; patients who want to discontinue the study at any time.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| CK-MB level. Timepoint: 12 hours Before, 8 and 24 hours after angioplasty. Method of measurement: ELISA.;CTnI level. Timepoint: Before, 8 and 24 hours after angioplasty. Method of measurement: ELISA. | — |
Secondary
| Measure | Time frame |
|---|---|
| Ck-mb,CT-ni. Timepoint: base line and 8 and 24 hours after. Method of measurement: elisa kit. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Taher Entezari-maleki
Tabriz University of Medical Sciences
Outcome results
None listed